Abstract
Aim. The work aims are to find and justify unified approaches to social reporting for pharmaceutical enterprises, which would enable the evaluation and comparison of the social activities of organizations across different market segments by all stakeholders. Materials and methods. Materials are scientific and scientific-methodical publications, regulatory and legislative documents on social responsibility, and information from the official websites of domestic manufacturing pharmaceutical enterprises, which were included in the top 20 marketing organizations by the volume of drugs’ pharmacy sales in 2022, to social reporting. Methods: critical analysis, content analysis, generalization, and interpretation of results. Results. The study found that while social reporting of pharmaceutical enterprises is an established practice abroad, there is no unified approach to their preparation, resulting in a diverse range of content. In Ukraine, it was observed that only JSC “Pharmak”, Arterium Corporation, and PJSC RPC “Borshchagivskyi chemical and pharmaceutical plant” publish reports on their corporate social responsibility. Other pharmaceutical companies provide information on their social measures either in management reports or in news. The phenomenon of social reporting of domestic pharmaceutical enterprises and the approaches to its preparation are still in the early stages of development. Therefore, this study proposes a framework for the content of such reports that caters to various stakeholders. Conclusions. Domestic manufacturing pharmaceutical enterprises apply different criteria and different approaches to inform society about their social activities, making it difficult to compare their contribution to the sustainable development of the country. It has been established that domestic pharmaceutical manufacturing enterprises need to strengthen their efforts in this direction. The preparation of transparent social reports based on international standards is one of the tools for promoting openness, improving the company’s activities, and ensuring accountability in the context of social responsibility.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: Current issues in pharmacy and medicine: science and practice
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.